Bayer Stock News

BASEL, Switzerland--(BUSINESS WIRE)--Bayer has launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in partnership with pharma packaging specialist Liveo Research, this innovative solution reduces the carbon footprint of this packaging by 38%1 and marks a stride in environmental stewardship by eliminat...

Bayer on Tuesday said it had applied for marketing authorization with the European Medicines Agency (EMA) for its menopause relief drug elinzanetant.

Der Leverkusener Pharma- und Agrarchemiekonzern Bayer DE000BAY0017 will das Mittel Elinzanetant gegen Hitzewallungen in den Wechseljahren in der Europäischen Union (EU) auf den Markt bringen.

Bayer said on Monday that it has applied to the EU's drugs regulator for the use of Nubeqa, also known as darolutamide, in combination with androgen deprivation therapy.

ORION CORPORATION INVESTOR NEWS 14 OCTOBER 2024 at 11.00 EEST          Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU Orion's collaboration partner Bayer today announced the submission of an application to the European Medicines Agency (EMA) for the oral androgen receptor inhibitor (ARi) darolutamide. Bayer is seeking approval for the use ...

Der Pharma- und Agrarchemiekonzern Bayer DE000BAY0017 hat für sein Medikament Nubeqa gegen Prostatakrebs die EU-Zulassung in einer weiteren Indikation beantragt.

Bayer DE000BAY0017 kommt beim Unternehmensumbau zügig voran.

Bayer DE000BAY0017 kommt beim Unternehmensumbau zügig voran.